What is Oaktree Acquisition Corp. II (OACC) stock price today?

Oaktree Acquisition Corp. II (OACC) is currently trading at $10.74, up 0.48% today.

What is OACC P/E ratio?

Oaktree Acquisition Corp. II's P/E ratio is 37.17. This is above the market average, reflecting high growth expectations.

What is OACC return on equity (ROE)?

Oaktree Acquisition Corp. II's return on equity (ROE) is 3.63%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Oaktree Acquisition Corp. II's market cap?

Oaktree Acquisition Corp. II has a market capitalization of $264.05M.

NASDAQ · Shell Companies

Oaktree Acquisition Corp. II (OACC) Stock

$10.74 +0.48% NASDAQ: OACC Financial Services

Oaktree Acquisition Corp. III Life Sciences does not have significant operations.

Valuation

Metric	Value
Price	$10.74
Market Cap	$264.05M
P/E Ratio	37.17
P/B Ratio	1.05
P/S Ratio	0.00
EPS (TTM)	$0.29
52-Week High	$10.74
52-Week Low	$10.30
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	3.63%
ROA	3.43%
ROCE	-0.59%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.87

Annual Financials (USD)

Metric	2024	2025
Revenue	$0	$0
Operating Profit	$0	$-1.0M
Net Profit	$0	$7.0M
EPS	$0.05	$0.30
Op Margin	—	—

Balance Sheet (USD)

Metric	2024	2025
Total Assets	$195.0M	$203.0M
Total Liabilities	$8.0M	$8.0M
Cash	$1.0M	$1.0M
Borrowings	$0	$0

Cash Flow (USD)

Metric	2024	2025
Operating Cash Flow	$0	$0
Investing Cash Flow	$-192.0M	$1.0M
Financing Cash Flow	$0	$0
Net Cash Flow	$1.0M	$0
Free Cash Flow	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.26
EV / EBITDA	-217.64
FCF Yield	-0.19%
Quick Ratio	0.87
Interest Coverage	0.00
Return 1Y	2.49%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held90.68%

Institutions Float Held90.68%

Institutional Holder	Shares	Report Date
AQR Arbitrage LLC	1,324,175	2026-03-31
Decagon Asset Management LLP	1,002,427	2026-03-31
Fort Baker Capital Management LP	1,000,000	2026-03-31
Empyrean Capital Partners, LP	900,000	2026-03-31
Shaw D.E. & Co., Inc.	861,625	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AACBArtius II Acquisition Inc. Class A Ordinary Shares	$10.57	+0.19%	32.03	$292.52M	0.00%
CGCT	$14.46	-7.01%	41.64	$399.10M	0.00%
COPLCopley Acquisition Corp	$10.45	+0.14%	88.67	$247.84M	0.00%
FACTFACT II Acquisition Corp	$10.64	+0.05%	48.56	$258.78M	0.00%
MBAVM3-Brigade Acquisition V Corp.	$10.87	-0.09%	0.18	$390.64M	0.00%

About Oaktree Acquisition Corp. II

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Oaktree Acquisition Corp. II is headquartered in US.

Oaktree Acquisition Corp. II (OACC) stock trades at $10.74 with a market capitalization of $264.05M. The stock is valued at a price-to-earnings (P/E) ratio of 37.17, price-to-book of 1.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.30 and $10.74, and currently trades at its 52-week high.

On profitability, Oaktree Acquisition Corp. II generates a return on equity (ROE) of 3.63%, return on capital employed of -0.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.oaktreeacquisitioncorp.com/oac-iii